How is the Incyte Corp. today?

The Incyte Corp. today is trading in the green, up by 4.83% at 70.81.

How has Incyte Corp. performed historically?

The Incyte Corp. is currently trading up 4.83% on an intraday basis in the past week the index rose 3.72%. The index has been up 14.06% in the past quarter and rose 12.22% in the past year. You can view this in the overview section.

What is Incyte Corp. Annual Revenue?

Incyte Corp. Annual Revenue rose 14.76%, in the last year to $4,241.22 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Incyte Corp. Annual Net Profit?

Incyte Corp. Annual Net Profit fell 94.54% in the last year to $32.62 M. Its sector's average net profit growth for the last fiscal year was -14.06%.

What is Incyte Corp. Price to Earning Ratio?

Incyte Corp. Price to Earning Ratio is 644.43, higher than its sector PE ratio of 4.53.

What is Incyte Corp. Stock Price?

Incyte Corp. Stock Price rose 12.22% and underperformed its sector by 38.77% in the past year.

What is Incyte Corp. Quarterly Revenue?

Incyte Corp. Quarterly Revenue rose 19.53% YoY to $1,052.9 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Incyte Corp. Quarterly Net profit?

Incyte Corp. Quarterly Net profit fell 6.69% YoY to $158.2 M. Its sector's average net profit growth YoY for the quarter was -236.03%.

What is Incyte Corp. Debt to Equity Ratio?

Incyte Corp. Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Incyte Corp. Return on Equity(ROE)?

Incyte Corp. Return on Equity(ROE) for the last financial year was 0.76%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Incyte Corp. Mutual Fund Holding?

Incyte Corp. Mutual Fund Holding increased by 0.15% in the last quarter to 58.34.

What is Incyte Corp. Promoter Share Holding?

Incyte Corp. Promoter Share Holding increased by 0.12% in the most recent quarter to 1.03%.

What is Incyte Corp. Interest Coverage Ratio?

Incyte Corp. Interest Coverage Ratio is 139.87, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Incyte Corp. Institutional Holding?

Incyte Corp. Institutional Holding remained the same in the last quarter at 98.85%.

Incyte Corp. XNAS: INCY

Incyte Corp. Live Share Price Today, Share Analysis and Chart

Name: Incyte Corp.: Is Infosys Ltd. worth buying?
Item: Incyte Corp.
Rating: 1.852041625
Author: Trendlyne DVM scores

Await Turnaround

about

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

70.81 3.26 (4.83%)

32.21% Gain from 52W Low

3.0M

XNAS Volume

XNAS 26 Jun, 2025 4:04 PM (EDT)

CEO Appointment

Incyte rises as it appoints Bill Meury as its CEO, succeeding Herve Hoppenot, effective immediately See details

Low Financial Strength

33.3 / 100

Mid Valuation

35.2 / 100

Technically Neutral

46.3 / 100

Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM

1Yr Price target upside is 6%

23 analysts

Incyte Corp. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Incyte Corp. Live Share Price Today, Share Analysis and Chart

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

32.21% Gain from 52W Low

SWOT Analysis

Incyte Corp. Live Price Chart

Incyte Corp. FAQ

How is Incyte Corp. today?

Incyte Corp. today is trading in the green, and is up by 4.83% at 70.81.

How has Incyte Corp. performed historically?

Incyte Corp. is currently trading up 4.83% on an intraday basis. In the past week the stock rose 3.72%. stock has been up 14.06% in the past quarter and rose 12.22% in the past year. You can view this in the overview section.